Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Operating Margin: 2013-2025

Historic Operating Margin for Ocular Therapeutix (OCUL) over the last 13 years, with Sep 2025 value amounting to -472.35%.

  • Ocular Therapeutix's Operating Margin fell 17414.00% to -472.35% in Q3 2025 from the same period last year, while for Sep 2025 it was -449.66%, marking a year-over-year decrease of 21975.00%. This contributed to the annual value of -269.57% for FY2024, which is 12861.00% down from last year.
  • Latest data reveals that Ocular Therapeutix reported Operating Margin of -472.35% as of Q3 2025, which was up 6.01% from -502.57% recorded in Q2 2025.
  • Ocular Therapeutix's 5-year Operating Margin high stood at -127.41% for Q3 2023, and its period low was -597.47% during Q1 2025.
  • In the last 3 years, Ocular Therapeutix's Operating Margin had a median value of -265.13% in 2024 and averaged -292.07%.
  • In the last 5 years, Ocular Therapeutix's Operating Margin skyrocketed by 96,719bps in 2021 and then plummeted by 38,346bps in 2025.
  • Quarterly analysis of 5 years shows Ocular Therapeutix's Operating Margin stood at -146.64% in 2021, then spiked by 909bps to -137.56% in 2022, then spiked by 209bps to -135.46% in 2023, then crashed by 16,061bps to -296.08% in 2024, then tumbled by 17,414bps to -472.35% in 2025.
  • Its Operating Margin stands at -472.35% for Q3 2025, versus -502.57% for Q2 2025 and -597.47% for Q1 2025.